.avif)
SAN DIEGO - Scientist.com is pleased to announce its online compliance solution COMPLiTM was recognized as the winner of the prestigious Regulatory Procedures and Compliance award at the 2018 CPhl Pharma Awards held in Madrid, Spain on October 9, 2018. COMPLiTM is a first-of-its-kind solution that allows pharmaceutical and biotech companies to confidently outsource regulated services such as human biological sample (HBS) acquisition, secondary real-world evidence (RWE), health economics and outcomes research (HEOR) and GxP services.
“COMPLiTM enables research organizations to address the biggest challenges they face when sourcing regulated services: transparency, visibility and control,” stated Matt McLoughlin, VP of Compliance at Scientist.com. “COMPLiTM addresses compliance and governance requirements at every critical step of the sourcing process to speed up drug research and reduce the associated risks of outsourcing.”
By simplifying and standardizing processes that previously took months, COMPLiTM shortens the research cycle and increases the pace of research. COMPLI™ also helps researchers and suppliers adhere to internal and external (often legislative) procurement policies and regulations. It ensures that, where required, appropriate ethical consents have been obtained, tracked and communicated throughout the supply chain.
Established in 2004, the CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. The CPhl Pharma Awards celebrate thinkers and creators breaking new ground and strongly advocate companies committed to driving the industry forward.
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。